TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vaccinova AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
70,067
|
35,709
|
26,455 |
Financial expenses |
15
|
23
|
12 |
Earnings before taxes |
7,189
|
-557
|
622 |
EBITDA |
7,418
|
-386
|
728 |
Total assets |
14,033
|
5,522
|
4,757 |
Current assets |
13,010
|
4,848
|
4,306 |
Current liabilities |
6,586
|
3,893
|
2,469 |
Equity capital |
7,406
|
1,612
|
2,137 |
- share capital |
51
|
47
|
49 |
Employees (average) |
35
|
25
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.8%
|
29.2%
|
44.9% |
Turnover per employee |
2,002
|
1,428
|
1,323 |
Profit as a percentage of turnover |
10.3%
|
-1.6%
|
2.4% |
Return on assets (ROA) |
51.3%
|
-9.7%
|
13.3% |
Current ratio |
197.5%
|
124.5%
|
174.4% |
Return on equity (ROE) |
97.1%
|
-34.6%
|
29.1% |
Change turnover |
31,824
|
10,049
|
14,714 |
Change turnover % |
83%
|
39%
|
125% |
Chg. No. of employees |
10
|
5
|
15 |
Chg. No. of employees % |
40%
|
25%
|
300% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.